OnKure Therapeutics, Inc.OKUR

OnKure Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery and development of best-in-class precision medicines that target biologically validated drivers of vascular anomalies and cancers underserved by available therapies. Using a structure and computational chemistry-driven drug design platform, OnKure aims to become a leader in targeting PI3Kα and has multiple programs designed to enable best-in-class targeting of this molecular target.

Key ratios

Recent news

Figures are sourced from third parties and shown for research only. They may be delayed or incomplete, and nothing on this page is investment advice or a recommendation to buy or sell. Read the full disclaimer